Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference
To kick off the first full day of the conference (July 18th), there will be a series of discussions starting with a General Session on 'Embracing Disruption, Driving Innovation. Minimally Invasive Spine.' Within this General Session, there will be two discussions with relevancy to Aurora Spine products: Surgical Approaches to Facet Disease and Posterior Approaches to Lumbar Spine and SI Joint.
On Saturday, July 19th, Aurora's ZIP product series will be highlighted in an ASPN Top Abstract discussion, of which only 12 are selected out of 330 papers that were submitted. Steven Falowski, MD, will deliver the podium talk to discuss: Functional Outcomes in the Low Back Pain Subject with a Novel Interspinous Fusion Device: REFINE Study 12 Month Results.
Later that day, Aurora Spine will be sponsoring the ASPN Charity Reception with beneficiaries being the IRONMAN Foundation and Return to Duty.
'We are very excited about this year's ASPN Conference, especially having been selected for a podium talk that highlights our ZIP series of products. We are extremely honored to be selected for this discussion, as there are only a few spots for selection,' said Trent Northcutt, President and CEO of Aurora Spine. 'We are also excited about this year's ASPN Conference as we'll be introducing our AERO Lumbar Fusion System to industry professionals in attendance, which will include in excess of 3,000 industry professionals including neuro, ortho and pain interventionalists.'
For more information about the conference go to: ASPN Annual Conference July 2025 .
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of proprietary, minimally invasive, and regenerative technologies. The company is committed to improving surgical outcomes through innovation, efficiency, and patient-centered design.
For more information, visit: www.aurora-spine.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, many of which are beyond Aurora Spine's control. Forward-looking statements include, but are not limited to, statements regarding the expected use and success of the Company's products, including the AERO Lumbar Fusion System. Actual results may differ materially. Please refer to Aurora Spine's final prospectus and public filings for additional information on risks and uncertainties.
These forward-looking statements speak only as of the date of this release. Aurora Spine undertakes no obligation to revise or update them to reflect future events or circumstances.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
2 hours ago
- CBS News
Aurora theater shooting survivor helps organize blood drive in honor of 12 killed
Sunday marks thirteen years since twelve lives were taken inside an Aurora movie theater. Dozens more were injured on July 20, 2012, and donated blood was a critical tool in saving many lives. In honor of the 12 people killed and the lives saved thanks to blood donations, a survivor of the theater shooting is helping to organize a first-ever blood drive at the Century Aurora Theater. Dylan Boxer was in theater 9 with a friend when the gunman opened fire. From his seat in the fourth row, not far from where the shooter entered the theater, Boxer narrowly escaped. "This is where I almost died," he said, standing in the parking lot of the movie theater. That same parking lot is where Boxer, now an account manager with Vitalant, has planned the mobile blood drive on July 20, 2025. "It's a chance to bring life back to where life was lost," said Boxer. "It's very poetic to have a life-saving event in a place on a day remembered in infamy for loss of life and tragedy. Having it here just seems right, and having it be on that day, it just clicks into place." Vitalant, one of the nation's largest nonprofits focused on blood and biotherapies, is working alongside the 7/20 Memorial Foundation for the mobile blood drive. The event will also include support from other theater shooting survivors, first responders, local leaders and other nonprofits. The goal is to fill every donation slot to save as many lives as possible during the nearly 5-hour blood drive. "The fact that we're doing the opposite of great harm [at the theater] and we're doing good, it really brings it full circle. We're saving lives now," Boxer said. "Each donation saves three lives." Organizers are encouraging donors to sign up online, via Vitalant's website, but walk-ins will also be accepted. 7/20 MEMORIAL MOBILE BLOOD DRIVE WHEN: Sunday, July 20, 2025, from 11:00 a.m. to 3:30 p.m. WHERE: On the bloodmobile in the parking lot of the Century Aurora Theater, 14300 E Alameda Avenue
Yahoo
3 hours ago
- Yahoo
Titan Logix Corp. Reports Its Fiscal 2025 Q3 and YTD Financial Results
(In $000's of Canadian dollars except for shares and per share amounts) Edmonton, Alberta--(Newsfile Corp. - July 16, 2025) - Titan Logix Corp., (TSXV: TLA) ("Titan" or the "Company"), a technology company specializing in mobile liquid measurement solutions, announces its interim results for the three- and nine-month periods ended May 31, 2025. "We are on track to begin field trials of our new product line for the refined petroleum market by the end of the fiscal year," says Nick Forbes, CEO at Titan. "This will be a key enabler for our growth into new markets by delivering innovative technology with a proven track record." The upcoming launch of our new product line, designed to meet specific customer needs in the refined fuels market, will drive new pilot trial and sales opportunities. Notably, the Company achieved CSA certification on its new FINCH display in the third quarter, and we are on track to begin field trials of the new product line by the end of the fourth fiscal quarter. This product, based on our proven TD-series platform, offers several key differentiators: Reliable overfill protection and rack control, giving refined petroleum fleets flexibility in rack, and non-rack loading environments. Enhanced safety and efficiency, displaying highly accurate liquid level measurement with improved performance over previous generation TD-series products. A compelling value proposition for fleet operators through integration with Titan's cloud-connected digital strategy. In parallel, Titan continued onboarding key dealer and OEM accounts into its Titan Install mobile application and Titan Portal back-office platform. These tools have been praised by channel partners for their intuitive design, ease of use, and modern capabilities. Our digital strategy remains a core differentiator, strengthening Titan's market position. YTD & Q3 FISCAL 2025 HIGHLIGHTS Revenues for the first nine months of fiscal 2025 were consistent with fiscal 2024 with only a modest decrease of $46 or 1% to $5,145 compared to $5,191 for the same period in fiscal 2024. However, revenues for the third quarter of fiscal 2025 decreased by $436 or 23% to $1,489 compared to $1,926 in the third quarter of fiscal 2024, as the uncertainty and threat of tariffs on sales to the Company's US market continued to have a negative impact in the current quarter. Gross Profit through the first nine months of fiscal 2025 increased slightly by $29 to $2,635 or 51% of revenues compared to $2,606 or 50% of revenues in the comparative period. The increase in Gross Profit resulted from lower key manufacturing input costs and stronger US dollar when compared to the same period in fiscal 2024. Gross Profit decreased by $296 to $708 or 48% of revenue in the third quarter of fiscal 2025 compared to $1,004 or 52% of revenue in the same quarter of fiscal 2024 due mainly to reduced revenue volumes. The performance of the CORE business, measured by Operating EBITDA(1), has increased by 22% through the first nine months of the fiscal 2025 to $968, compared to $792 through same period in fiscal 2024. Operating EBITDA(1) declined by $327 or 80% in the third quarter of fiscal 2025 however, with reported Operating EBITDA of $83 compared to $410 in the same period of fiscal 2024, a direct result of the reduced volume experienced in the third fiscal quarter compared to the third quarter of fiscal 2024. Product research and development expenses increased by $201 to $999 in the current fiscal 2025 year compared to $798 in the same period of fiscal 2024, with the third quarter product research and development expenses increasing by $82 to $368 in the current fiscal quarter compared to $285 in the same quarter of fiscal 2024. The expenses incurred support the Company's diversification and growth into new markets. The Company's net loss has improved by $153 to a net loss of $225 in the current fiscal year compared to a net loss of $378 in the same period of fiscal 2024, this decrease resulted from lower unrealized losses on marketable securities in the current year. The Company's net loss in the third quarter increased by $202 to a net loss of $421 compared to a net loss of $202 in the third quarter of fiscal 2024 due mainly to the current period reduction in volume experienced. Financial Highlights SummaryThree months ended Nine months ended 2025 2024 2025 2024 $ $ $ $ Revenue 1,489 1,926 5,145 5,191 Cost of sales (782) (922) (2,510) (2,584) Gross profit 708 1,004 2,635 2,606 Gross margin (%) 48% 52% 51% 50% Operating EBITDA (1) 83 410 968 892 Product research and development expenses (1) (368) (285) (999) (798) EBITDA (1) (285) 125 (31) 93 Net loss (421) (218) (225) (378) EPS - Basic and Diluted (0.01) (0.01) (0.01) (0.01) Financial Position As at May 31, 2025 As at August 31, 2024 Working capital $ 15,345 $ 14,139 Total assets $ 18,602 $ 19,022 Long-term liabilities $ 494 $ 600 Total equity $ 17,171 $ 17,502 (1) See Non-IFRS measures below. The Company's unaudited, condensed, consolidated interim financial statements and the management's discussion and analysis ("MD&A") which includes the Company's Business Outlook, for the three- and nine-month periods ended May 31, 2025, are available on SEDAR+ at and the Company's website, NON-IFRS MEASURES The Company uses certain measures in this MD&A that do not have a standardized meaning as prescribed by IFRS (International Financial Reporting Standards) and thus are prohibited from being disclosed in the consolidated financial statements. These measures, which are derived from information reported in the Company's consolidated financial statements, may not be consistent with similar measures presented and disclosed by other reporting issuers. However, management believes that this information provides increased insight into the Company's strategic plan to address the broader mobile liquid markets. Readers are cautioned that these Non-IFRS measures should not be construed as alternatives to other measures of financial performance calculated in accordance with IFRS. The table below provides a reconciliation of the Company's EBITDA and Operating EBITDA to the Operating income (loss) before other items per the interim consolidated financial statements for the periods presented: Fiscal Period Ended Q3 2025 Q3 2024 YTD 2025 YTD 2024 Operating income (loss) before other items (388) 2 (416) (245) Add: Depreciation and amortization 96 99 289 283 Add: Non-cash stock-based compensation 7 24 96 55 EBITDA (285) 125 (31) 93 Add: Product research and development expenses (1) 368 285 999 798 Operating EBITDA 83 410 968 892 The table below, removes the recurring engineering expenses from the total to isolate the product research and development expenses excluded in Management's calculation of Operating EBITDA: Fiscal Period Ended Q3 2025 Q3 2024 YTD 2025 YTD 2024 Engineering, product research and development expenses (396) (333) (1,088) (949) Less: Recurring engineering expenses 28 47 88 150 Product research and development expenses (368) (285) (999) (798) (1) A detailed definition of these Non-IFRS measures can be reviewed in the Company's MD&A About Titan Logix Corp.: For over 25 years, Titan Logix Corp. has designed and manufactured mobile liquid measurement solutions to help businesses reduce risk and maximize efficiencies in bulk liquids transportation. Titan's TD Series of tank level monitors are a market leader in mobile fluid measurement, and are known for their high level of accuracy, rugged design, and solid-state reliability. Our solutions are designed for hazardous and non-hazardous applications, and we serve customers in a wide range of applications including petroleum, environmental solutions, chemical, and agriculture. Founded in 1979, Titan Logix Corp. is a public company listed on the TSX Venture Exchange and its shares trade under the symbol TLA. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Information in this press release that is not current or historical factual information may constitute forward looking information within the meaning of securities laws. Implicit in this information are assumptions regarding our future operational results. These assumptions, although considered reasonable by the Company at the time of preparation, may prove to be incorrect. Readers are cautioned that the actual performance of the Company is subject to many risks and uncertainties and could differ materially from what is expected as set out above. For more exhaustive information on these risks and uncertainties you should refer to our Management Discussion and Analysis in respect of the year ended August 31, 2024, which is available at In addition, the occurrence of pandemics, such as the outbreak of the novel coronavirus COVID-19 in any of the areas in which the Company, its customers or its suppliers operate could cause interruptions in the Company's operations. In addition, pandemics, natural disasters, or other unanticipated events could negatively impact the demand for, and price of, oil and natural gas which in turn could have a material adverse effect on the Company's business, financial condition, results of operations and cash flows. The forward-looking information contained in this press release is based on our current estimates, expectations, and projections, which we believe are reasonable as of the current date. You should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While we may elect to, we are under no obligation and do not undertake to update this information at any time, whether a result of new information, future events or otherwise, except as required by applicable securities law Contact Information: Nick ForbesChief Executive OfficerPh: (403) 561-8095Email: invest@ Venture, TLA To view the source version of this press release, please visit
Yahoo
3 hours ago
- Yahoo
Northisle Announces C$30 Million Financing
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, British Columbia, July 16, 2025--(BUSINESS WIRE)--NorthIsle Copper and Gold Inc. (TSXV: NCX, OTCQX:NTCPF) ("NorthIsle" or the "Company") is pleased to announce that it has entered into an agreement with Paradigm Capital Inc. ("Paradigm") as lead agent and sole bookrunner on behalf of a syndicate of agents (collectively, the "Agents"), in connection with a "best efforts" private placement financing (the "Brokered Offering") for total proceeds of up to approximately $25,002,747, consisting of up to 9,338,000 common shares of the Company that qualify as "flow-through shares" (within the meaning of subsection 66(15) of the Income Tax Act (Canada)) (the "CFT Shares") to be issued to subscribers at a price of $1.6065 per CFT Share, and up to 9,525,000 common shares of the Company (the "Non-FT Shares" and together with the CFT Shares, the "Offered Shares") at a price of $1.05 per common share. In addition, the Company has granted the Agents an option (the "Agents' Option") to sell additional Offered Shares at the same issue prices for additional aggregate gross proceeds of up to $3,750,412, exercisable not later than 48 hours prior to the Closing Date (as defined below). The term "Offering" includes the additional Offered Shares that may be issued on the exercise of the Agents' Option, if any. The Offering is anticipated to include participation from new and existing fundamental institutional investors and existing cornerstone shareholders. Concurrent to the Brokered Offering, the Company will conduct a non-brokered private placement of 4,762,000 Non-FT Shares at a price of $1.05 per common share to raise up to C$5,000,100 (the "Non-Brokered Offering"). Wheaton Precious Metals Corp. has indicated its intention to subscribe in the Non-Brokered Offering subject to entering into a right of first refusal agreement with Northisle, to be negotiated in good faith, and certain other conditions. The Company will use an amount equal to the gross proceeds received by the Company from the sale of the CFT Shares to incur eligible "Canadian exploration expenses" that qualify as "flow-through critical mineral mining expenditures" as such terms are defined in the Income Tax Act (Canada) (the "Critical Minerals Qualifying Expenditures"). The Company will incur the Critical Minerals Qualifying Expenditures on or before December 31, 2026, and renounce (on a pro rata basis) all such expenditures in favour of the subscribers of the CFT Shares with an effective date no later than December 31, 2025 in accordance with the Income Tax Act (Canada). The proceeds from the sale of the Non-FT Shares will be used for general corporate and working capital purposes as described in the offering document for the Offering. Closing is expected to occur on or about August 8, 2025, or other such date as the Company and the Agents may agree (the "Closing Date"). The Offering is subject to regulatory approval, including the approval of the TSX Venture Exchange (the "TSXV"). The Offered Shares will be offered for sale to purchasers resident in Canada, except Quebec, pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106") and in such other jurisdictions as may be mutually agreed upon by the Agents and the Company. The Offered Shares will not be subject a statutory hold period in Canada (except to the extent the TSXV's four-month hold period applies). There is an offering document related to the Offering that can be accessed under the Company's profile at and at Prospective investors should read this offering document before making an investment decision. The securities have not been, and will not be, registered under the Unites States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any U.S. state securities laws, and may not be offered or sold in the United States without registration under the U.S. Securities Act and all applicable state securities laws or compliance with requirements of an applicable exemption therefrom. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the Unites States, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. About Northisle Northisle Copper and Gold Inc. is a Vancouver-based company whose mission is to become a leading and sustainable mineral resource company for the future. Northisle owns the North Island Project, which is one of the most promising copper and gold porphyry deposits in Canada. The North Island Project is located near Port Hardy, British Columbia on a more than 34,000-hectare block of mineral titles 100% owned by Northisle stretching 50 kilometres northwest from the now closed Island Copper Mine operated by BHP Billiton. Northisle recently completed an updated preliminary economic assessment for the North Island Project and is now focused on advancement of the project through a prefeasibility study while continuing exploration within this highly prospective land package. For more information on Northisle please visit the Company's website at This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Cautionary Statements regarding Forward-Looking Information Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "intend" and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements relating to the ability to complete the Offering on the proposed terms or at all, anticipated use of proceeds from the Offering, the participation of certain insiders and others in the Offering, and receipt of regulatory approvals with respect to the Offering as well as any other future plans, objectives or expectations of Northisle. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, Northisle's ability to implement its business strategies; risks associated with mineral exploration and production; risks associated with general economic conditions; adverse industry events; stakeholder engagement; marketing and transportation costs; loss of markets; volatility of commodity prices; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; industry and government regulation; changes in legislation, income tax and regulatory matters; competition; currency and interest rate fluctuations; and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions, or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release represent the expectations of management of Northisle as of the date of this news release, and, accordingly, are subject to change after such date. Northisle does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV ) accepts responsibility for the adequacy or accuracy of this news release. View source version on Contacts On behalf of Northisle Copper and Gold Inc. Nicholas Van Dyk, CFA Chief Financial OfficerTel: (604) 638-2515Email: info@
